Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Scope of the Report:
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Based on technology, the market is categorized into polymeric drug delivery, implants & IUD's, sustained release, targeted drug delivery and prodrugs. By polymeric drug delivery, the market is further divided into nebulizers, metered dose inhalers and dry powder inhalers.
By end user, the market is segregated into hospitals, diagnostic centers, ambulatory surgical centers/clinics, home care settings and other end users.
The global Advanced Drug Delivery market is valued at 340 million USD in 2017 and is expected to reach 520 million USD by the end of 2023, growing at a CAGR of 7.5% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Advanced Drug Delivery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Advanced Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Advanced Drug Delivery market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck & Co
F. Hoffmann-La Roche
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Polymeric Drug Delivery
Implants & IUD's
Targeted Drug Delivery
Market Segment by Applications, can be divided into
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users